Skip to content

Markers of Carnitine Acetyltransferase (CrAT) Protein Activity and Carnitine Availability

Searching for Non-invasive Magnetic Resonance-based Markers for CrAT Protein Activity and Carnitine Availability in Skeletal Muscle

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03697928
Enrollment
13
Registered
2018-10-05
Start date
2019-03-12
Completion date
2020-02-01
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Disturbance, Metabolism and Nutrition Disorder

Keywords

Acetylcarnitine kinetic, Phosphocreatine (PCr) kinetic

Brief summary

This study aims to measure skeletal muscle metabolism in vivo during exercise using the non-invasive Magnetic Resonance Spectroscopy (MRS) technique. Specifically, phosphocreatine (PCr) kinetic and Acetylcarnitine levels will be determined at resting, during exercise and during the recovery post exercise. The target population is adult healthy men, with a wide range of maximal physical capacity.

Detailed description

Skeletal muscle mitochondrial activation during the transition from resting metabolism to exercise may modulated by CrAT activity. Furthermore, dynamic changes in acetylcarnitine during the transition from exercise to resting metabolism (acetylcarnitine off-kinetic) may also reflect the action of CrAT protein. To date, the only possibility to get information on CrAT activity is by taking a muscle biopsy and perform enzyme activity assays ex vivo. By dynamic MRS scanning, it might be possible to deduce information that reflects CrAT activity, thereby making the biopsy sampling unnecessary.

Interventions

OTHERExercise metabolism

Participants will perform a series of exercises inside and outside the MRS/MRI scanner.

Sponsors

Maastricht University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Males, Generally healthy * Age 18-40 years old * BMI 18 - 25 kg/m2 * No medication use that interfere with the aims of the study * Stable level of daily physical activity or training for at least 6 months

Exclusion criteria

* Females * Regular smokers, drug abuse * Participation in other studies * Weight gain/loss \> 3 kg in the last 6 months * Contraindications for MRS scans: * Vegetarian eating behavior

Design outcomes

Primary

MeasureTime frameDescription
Skeletal muscle PCr on-kinetic during exercise and carnitine acetyltransferase (CrAT) protein content/activityMRS+Exercise test day 2The correlation between skeletal muscle PCr on-kinetic during one-legged exercise and CrAT protein activity will be determined.

Secondary

MeasureTime frameDescription
Skeletal muscle acetylcarnitine recovery after one-legged exercise and carnitine acetyltransferase (CrAT) protein content/activityMRS+Exercise test day 2The correlation between skeletal muscle acetylcarnitine off-kinetic after one-legged exercise and CrAT protein activity will be determined.
Skeletal muscle CrAT protein activity, from muscle biopsy, and PCr breakdown rate during one-legged exerciseMRS+Exercise test day 1The correlation between CrAT protein activity and PCr hydrolysis/breakdown will be determined
Skeletal muscle acetylcarnitine formation capacity upon exercise and total carnitine availability in skeletal muscleMRS+Exercise test day 2The correlation between acetylcarnitine formation upon exercise and total carnitine availability will be determined
Skeletal muscle mitochondrial function in vitroMRS+Exercise test day 2The association between Skeletal muscle mitochondrial function in vitro and in vivo
Skeletal muscle oxygen availabilityMRS test day 1in vivo assessment of oxygen availability in muscle tissue upon hypoxic stimulus during resting

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026